TP53 and cancer: To overcome these challenges, research is focusing on novel approaches such as small molecules that stabilize or reactivate mutant p53, synthetic lethality strategies that exploit vulnerabilities in p53-deficient tumors, and immunotherapies that target p53-expressing cancer cells.